HENLIUS: JOINT ANNOUNCEMENT - (1) POLL RESULTS OF THE EXTRAORDINARY GENERAL MEETING AND THE H SHAREHOLDERS' CLASS MEETING RELATING TO THE PROPOSED PRIVATISATION OF HENLIUS BY FOSUN NEW MEDICINE BY WAY OF MERGER BY ABSORPTION OF HENLIUS AND (2) TERMINATION OF THE ME
HENLIUS: VOLUNTARY ANNOUNCEMENT - APPLICATION FOR PHASE 1B/2 CLINICAL TRIAL OF HLX43FOR INJECTION (ANTIBODY-DRUG CONJUGATE TARGETINGPD-L1 WITH NOVEL DNA TOPOISOMERASE I INHIBITOR) INCOMBINATION WITH HANSIZHUANG (SERPLULIMAB INJECTION)FOR THE TREATMENT OF PATIENTS W
HENLIUS: UPDATE ON QUALIFICATION OF THE JOINT COMPANY SECRETARY
HENLIUS: Disclosure of Dealings under Rule 22 of the Takeovers Code
HENLIUS: Disclosure of Dealings under Rule 22 of the Takeovers Code
HENLIUS: Disclosure of Dealings under Rule 22 of the Takeovers Code
HENLIUS: Disclosure of Dealings under Rule 22 of the Takeovers Code
HENLIUS: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2024
HENLIUS: Disclosure of Dealings under Rule 22 of the Takeovers Code
HENLIUS: Disclosure of Dealings under Rule 22 of the Takeovers Code
HENLIUS: Disclosure of Dealings under Rule 22 of the Takeovers Code
HENLIUS: Disclosure of Dealings under Rule 22 of the Takeovers Code
HENLIUS: Disclosure of Dealings under Rule 22 of the Takeovers Code
HENLIUS: Disclosure of Dealings under Rule 22 of the Takeovers Code
HENLIUS: CONTINUING CONNECTED TRANSACTIONS -RENEWAL OF THE PROMOTIONAL SERVICES AGREEMENT
HENLIUS: Disclosure of Dealings under Rule 22 of the Takeovers Code
HENLIUS: Disclosure of Dealings under Rule 22 of the Takeovers Code
HENLIUS: Disclosure of Dealings under Rule 22 of the Takeovers Code
HENLIUS: Disclosure of Dealings under Rule 22 of the Takeovers Code
HENLIUS: Disclosure of Dealings under Rule 22 of the Takeovers Code